Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1979 1
1980 1
1981 5
1982 3
1984 1
1986 2
1987 1
1990 2
1991 3
1992 4
1993 1
1996 2
1998 4
1999 2
2000 3
2001 4
2003 7
2004 1
2005 2
2007 1
2008 3
2009 3
2010 4
2011 1
2012 4
2013 3
2014 4
2015 3
2016 8
2017 5
2018 6
2019 9
2020 15
2021 20
2022 16
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, Cisneros JM, Dolores Navarro M, Fätkenheuer G, Jung N, Rieg S, Lepeule R, Coutte L, Bernard L, Lemaignen A, Kösters K, MacKenzie CR, Soriano A, Hagel S, Fantin B, Lafaurie M, Talarmin JP, Dinh A, Guimard T, Boutoille D, Welte T, Reuter S, Kluytmans J, Martin ML, Forestier E, Stocker H, Vitrat V, Tattevin P, Rommerskirchen A, Noret M, Adams A, Kern WV, Hellmich M, Seifert H; SABATO study group. Kaasch AJ, et al. Among authors: lafaurie m. Lancet Infect Dis. 2024 Jan 17:S1473-3099(23)00756-9. doi: 10.1016/S1473-3099(23)00756-9. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38244557
Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Lafaurie M, Chevret S, Fontaine JP, Mongiat-Artus P, de Lastours V, Escaut L, Jaureguiberry S, Bernard L, Bruyere F, Gatey C, Abgrall S, Ferreyra M, Aumaitre H, Aparicio C, Garrait V, Meyssonnier V, Bourgarit-Durand A, Chabrol A, Piet E, Talarmin JP, Morrier M, Canoui E, Charlier C, Etienne M, Pacanowski J, Grall N, Desseaux K, Empana-Barat F, Madeleine I, Bercot B, Molina JM, Lefort A; PROSTASHORT Study Group. Lafaurie M, et al. Clin Infect Dis. 2023 Jun 16;76(12):2154-2162. doi: 10.1093/cid/ciad070. Clin Infect Dis. 2023. PMID: 36785526 Clinical Trial.
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study.
Maillard A, Delory T, Bernier J, Villa A, Chaibi K, Escaut L, Contejean A, Bercot B, Robert J, El Alaoui F, Tankovic J, Poupet H, Cuzon G, Lafaurie M, Surgers L, Joseph A, Paccoud O, Molina JM, Bleibtreu A; Treatment of AmpC-producing Enterobacterales Study Group. Maillard A, et al. Among authors: lafaurie m. Int J Antimicrob Agents. 2023 Jul;62(1):106809. doi: 10.1016/j.ijantimicag.2023.106809. Epub 2023 Apr 6. Int J Antimicrob Agents. 2023. PMID: 37028731
Risk of Immune Thrombocytopenia After Influenza Vaccine.
Lafaurie M, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Lafaurie M, et al. JAMA Intern Med. 2022 Apr 1;182(4):444-445. doi: 10.1001/jamainternmed.2021.8523. JAMA Intern Med. 2022. PMID: 35188544 Free PMC article.
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases.
Boumaza X, Lafaurie M, Treiner E, Walter O, Pugnet G, Martin-Blondel G, Biotti D, Ciron J, Constantin A, Tauber M, Puisset F, Moulis G, Alric L, Renaudineau Y, Chauveau D, Sailler L. Boumaza X, et al. Among authors: lafaurie m. Int Immunopharmacol. 2023 Jul;120:110342. doi: 10.1016/j.intimp.2023.110342. Epub 2023 Jun 3. Int Immunopharmacol. 2023. PMID: 37276827
Multicenter Evaluation of the FilmArray Blood Culture Identification 2 Panel for Pathogen Detection in Bloodstream Infections.
Caméléna F, Péan de Ponfilly G, Pailhoriès H, Bonzon L, Alanio A, Poncin T, Lafaurie M, Dépret F, Cambau E, Godreuil S, Chenouard R, Le Monnier A, Jacquier H, Berçot B. Caméléna F, et al. Among authors: lafaurie m. Microbiol Spectr. 2023 Feb 14;11(1):e0254722. doi: 10.1128/spectrum.02547-22. Epub 2022 Dec 15. Microbiol Spectr. 2023. PMID: 36519852 Free PMC article.
Not all β-lactams are equal regarding neurotoxicity.
Chaïbi K, Chaussard M, Soussi S, Lafaurie M, Legrand M. Chaïbi K, et al. Among authors: lafaurie m. Crit Care. 2016 Oct 27;20(1):350. doi: 10.1186/s13054-016-1522-z. Crit Care. 2016. PMID: 27784324 Free PMC article. No abstract available.
Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
Lafaurie M, Montlahuc C, Kerneis S, de Lastours V, Abgrall S, Manceron V, Couzigou C, Chabrol A, de Raigniac A, Lescure X, Longuet P, Lesprit P, Vanjak D, Lepeule R; Groupe des référents en Infectiologie d’Ile de France (GRIF). Lafaurie M, et al. J Antimicrob Chemother. 2023 May 3;78(5):1253-1258. doi: 10.1093/jac/dkad083. J Antimicrob Chemother. 2023. PMID: 37014800
147 results